Lakefront Biotherapeutics (LKFT) Assets Average (2015 - 2026)
Lakefront Biotherapeutics (LKFT) reported Assets Average of $4.0 billion for Q1 2026, down 8.51% year-over-year from $4.3 billion in Q1 2025, and down 1.95% quarter-over-quarter from $4.0 billion in Q4 2025.
Lakefront Biotherapeutics (LKFT) Assets Average (2015 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has 12 years of Assets Average data on file, last reported at $4.0 billion in Q1 2026.
- Assets Average for Q1 2026 came in at $4.0 billion, down 8.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.0 billion (down 8.51% YoY), and the FY2025 annual result was $4.2 billion, down 7.94% from the prior year.
- Assets Average slipped to $4.0 billion in Q1 2026 per LKFT's latest filing, from $4.0 billion in the prior quarter.
- Over five years, Assets Average peaked at $5.8 billion in Q1 2022 and troughed at $4.0 billion in Q1 2026.
- A 5-year average of $4.6 billion and a median of $4.4 billion in 2025 frame the typical range for Assets Average.
- The sharpest annual moves came in 2023 and 2024: Assets Average decreased 15.97% in 2023, then slipped 3.83% in 2024.
- A 5-year view of Assets Average shows it stood at $5.8 billion in 2022, then decreased by 18.27% to $4.8 billion in 2023, then dropped by 5.59% to $4.5 billion in 2024, then slipped by 10.34% to $4.0 billion in 2025, then decreased by 1.95% to $4.0 billion in 2026.
- Business Quant data shows LKFT's Assets Average at $4.0 billion in Q1 2026, $4.0 billion in Q4 2025, and $4.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 660.38 Mn |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn | 3.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.96 Bn |
| Dec 31, 2025 | 4.04 Bn |
| Sep 30, 2025 | 4.21 Bn |
| Jun 30, 2025 | 4.28 Bn |
| Mar 31, 2025 | 4.33 Bn |
| Dec 31, 2024 | 4.50 Bn |
| Mar 31, 2024 | 4.71 Bn |
| Dec 31, 2023 | 4.77 Bn |
| Mar 31, 2023 | 4.90 Bn |
| Mar 31, 2022 | 5.83 Bn |
| Dec 31, 2021 | 6.24 Bn |
| Jun 30, 2020 | 6.53 Bn |
| Mar 31, 2020 | 6.67 Bn |
| Dec 31, 2019 | 6.61 Bn |
| Sep 30, 2019 | 4.02 Bn |
| Jun 30, 2019 | 1.56 Bn |
| Mar 31, 2019 | 1.62 Bn |
| Dec 31, 2018 | 1.69 Bn |
| Sep 30, 2018 | 864.66 Mn |
| Jun 30, 2018 | 756.18 Mn |